Toronto, Canada, August 18, 2022 – Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce that Medi-Call Inc., the Company’s wholly owned telehealth company, has added a cutting-edge Health Canada approved portable ultrasound device, Butterfly iQ+, which is used to aid in assessments during home and in-clinic visits by Medi-Call physicians.
Butterfly iQ+ Features
To learn more about the Butterfly iQ+ visit: www.butterflynetwork.com
In addition, the Company has further expanded its physicians and added Dr. Rashad Dindo to the Medi-Call team.
“We are thrilled to expand Medi-Call by offering new ultrasound services. Recent data shows wait times for services like ultrasounds can be up to 3-4 weeks. Being able to provide timely care for patients in a way that is accessible is priority”, said Marshall Gunter, CEO of the Company.
“The team is excited to have the latest in portable ultrasound technology at our fingertips. These devices allow our physicians to serve patient needs better, and faster by having accessible and on the go equipment, catering to numerous health services, and ultimately more efficient care,” said Omar Sharif, Chief Medical Officer of the Company.
Medi-call is a subscription-based software as a service (SaaS) mobile application that connects patients with doctors. It is an integrated grid system that connects patients with providers in real time. Medi-Call solves accessibility issues for patients living in rural or isolated communities and those also have limited mobility while improving coordination and communication of treatment among healthcare team members and their patients. Medi-Call facilitates mobile health care services, including prescriptions and is passionate about building doctor-patient relationships virtually.
Visit Medicallmd.ca to learn more about the Company.
Download the Medi-Call App for Android: https://bit.ly/MCGooglePlay
Download the Medi-Call App for iOS: https://apple.co/3oos9m2
Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, machine learning, telehealth and has recently entered the electric vehicle (EV) market. Datametrex’s mission is to provide tools and solutions that support companies in fulfilling their operational goals, including health and safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through artificial intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.
For further information:
Investor Relations & Communications
Priya Monique Atwal, Director of Communications
Tel: 416-901-5611 x 204
Marshall Gunter, CEO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements, including statements regarding the Bid. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.